Thyroid uptake test with portable device (COTI) after <sup>131</sup>I tracer administration: proof of concept.

Abuqbeitah M. , Demir M. , Yeyin N. , Sager S., Gray D.

Radiation and environmental biophysics, cilt.59, ss.553-558, 2020 (SCI Expanded İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 59
  • Basım Tarihi: 2020
  • Doi Numarası: 10.1007/s00411-020-00849-8
  • Dergi Adı: Radiation and environmental biophysics
  • Sayfa Sayıları: ss.553-558


COTI (collar therapy indicator) has been recently introduced for the detection of gamma rays with emphasis on thyroid investigations. The aim of this study was to test the feasibility of a prototype version of COTI including activity detectors with low sensitivity in performing thyroid uptake measurements for a large group of patients. Consequently, thyroid uptake tests were carried out for a total of 89 patients (22 males and 67 females; age: 44 +/- 13 years) with thyroid cancer (n = 74), hyperthyroidism (n = 16) at 2 and 24 h after administration of 0.44-2 MBq of I-131. Eight individuals among the thyroid cancer patients were monitored up to 96 h after administration. The COTI device was equipped with two CsI (Tl) detectors, known as LoHi type, sensitive to activity ranges from 0.02 to 30 MBq of I-131. The uptake values from COTI were compared with those measured with a standard probe. It was found that the mean uptake of thyroid activity in thyroid cancer patients was 2.1 +/- 1.3% at 2 h when measured with the standard probe, while it was 2.2 +/- 1.2% when measured with COTI. In addition, the average uptake at 24 h after administration was 2.5 +/- 3.2% and 3.2 +/- 3.8% measured with COTI and the standard probe, respectively. A strong correlation was found at 24 h between the results obtained with COTI and the standard probe, while a weaker correlation was seen at 2 h. Overall, there was no significant difference between the results obtained with the standard probe and those obtained with COTI at both 2 and 24 h (P-value >= 0.05). Besides, 85% of the uptake values measured with COTI were less than those measured with the standard probe at the 24 h after administration. The average uptake value was 0.9 +/- 0.8% after 96 h by COTI, and 1.4 +/- 1.3% by the standard probe. Pertaining to the hyperthyroidism patients, COTI showed mean uptake values of 20 +/- 16% and 23 +/- 18% at 2 and 24 h, respectively. In contrast, the standard probe suggested higher mean uptake values of 26 +/- 18% and 30 +/- 22%, respectively. It is concluded that the prototype of COTI used in the present study has been proved to be a feasible and promising tool in thyroid investigations. It is noted, however, that the next COTI generation should include detectors equipped with collimator and energy discrimination.